KPIs & Operating Metrics(New)
Growth Metrics

Teva Pharmaceutical Industries (TEVA) Cash & Equivalents Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Equiv. Growth (3y) (Qtr)
1 Haleon 111.53 Bn 109.67 Bn - 29.96%
2 Teva Pharmaceutical Industries 39.57 Bn 35.83 Bn 1.97 Bn 20.41%
3 Zoetis 33.84 Bn 31.90 Bn 1.62 Bn -2.73%
4 United Therapeutics 24.62 Bn 22.47 Bn 648.10 Mn 3.22%
5 Aurora Cannabis 17.89 Bn 17.81 Bn 33.43 Mn -49.65%
6 Neurocrine Biosciences 15.75 Bn 14.43 Bn 800.70 Mn 36.93%
7 Regencell Bioscience Holdings 13.55 Bn 13.55 Bn - -
8 Elanco Animal Health 10.61 Bn 10.18 Bn 785.00 Mn 10.41%
9 HUTCHMED (China) 10.36 Bn 9.02 Bn - -43.23%
10 Alkermes 6.14 Bn 5.63 Bn -116.06 Mn 3.03%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 20.41%
Dec 31, 2025 8.28%
Sep 30, 2025 -0.33%
Jun 30, 2025 1.64%
Mar 31, 2025 -7.94%
Dec 31, 2024 15.08%
Sep 30, 2024 17.52%
Jun 30, 2024 -2.50%
Mar 31, 2024 19.72%
Dec 31, 2023 14.01%
Sep 30, 2023 7.17%
Jun 30, 2023 3.58%
Mar 31, 2023 5.91%
Dec 31, 2022 12.35%
Sep 30, 2022 21.48%
Jun 30, 2022 -1.68%
Mar 31, 2022 3.30%
Dec 31, 2021 6.70%
Sep 30, 2021 2.94%
Jun 30, 2021 9.39%
Mar 31, 2021 7.12%
Dec 31, 2020 31.24%
Sep 30, 2020 22.74%
Jun 30, 2020 58.87%
Mar 31, 2020 22.22%
Dec 31, 2019 25.97%
Sep 30, 2019 -43.68%
Jun 30, 2019 -32.20%
Mar 31, 2019 -34.26%
Dec 31, 2018 -36.46%
Sep 30, 2018 -5.56%
Jun 30, 2018 -5.80%
Mar 31, 2018 -25.26%
Dec 31, 2017 -24.37%
Sep 30, 2017 -12.46%
Jun 30, 2017 -16.75%
Mar 31, 2017 -1.63%
Dec 31, 2016 -1.63%
Sep 30, 2016 82.22%
Jun 30, 2016 34.12%
Mar 31, 2016 70.80%
Dec 31, 2015 34.12%
Sep 30, 2015 26.64%
Jun 30, 2015 26.64%
Mar 31, 2015 47.33%
Dec 31, 2014 26.64%
Sep 30, 2014 5.68%
Jun 30, 2014 -3.05%
Mar 31, 2014 12.92%
Dec 31, 2013 -5.96%
Sep 30, 2013 7.08%
Jun 30, 2013 13.01%
Mar 31, 2013 -11.26%
Dec 31, 2012 13.01%
Sep 30, 2012 -11.81%
Jun 30, 2012 -22.45%
Mar 31, 2012 -16.95%